Mann joins Nutrition 21 board
PURCHASE, N.Y. Nutrition 21 on Wednesday announced that Peter Mann has joined its board effective Oct. 15.
Mann is a senior consumer and pharmaceutical products business executive with more than 35 years of general management, marketing and sales experience. In 2001, Mann was one of the founders and served as the chief executive officer of MedTech Holdings, which subsequently became Prestige Brands. Mann retired as chairman and chief executive officer of Prestige Brands Holdings in January.
“We are delighted that an industry leader of Peter Mann’s caliber has agreed to join our board,” stated Paul Intlekofer, Nutrition 21 president and chief executive officer. “In addition to being one of the most effective executives in the consumer products industry, he is a visionary who has created markets for many of the brands that we use on a regular basis to improve the quality of our lives. His broad industry experience and expertise will be instrumental to Nutrition 21 as we continue to progress on our strategic plan.”
Mann is a graduate of Brown University. He is currently a member of the Consumer Healthcare Products Association Board of Directors.
House passes Dextromethorphan Distribution Act; NACDS, CHPA applaud
WASHINGTON Both the Consumer Healthcare Products Association and the National Association of Chain Drug Stores commended the U.S. House of Representatives passing of H.R. 970, the Dextromethorphan Distribution Act of 2007, on Monday, which prohibits the distribution of raw dextromethorphan, an active ingredient commonly found in over-the-counter cough medicines, to any person other than FDA-registered producers of drugs and devices. On that point, NACDS would opt for the approach of Senate companion legislation, which would maintain the availability of bulk DXM to pharmacies for use in compounding.
“Today’s vote demonstrates the commitment of U.S. Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash. … and the bill’s 22 co-sponsors to protecting America’s youth from this serious threat,” stated Linda Suydam, CHPA president. “This bipartisan legislation is vital to protecting America’s youth from unscrupulous online pushers who willingly provide kids with the raw form of dextromethorphan as a means to get high.
“NACDS and its members are committed to the health of communities,” added Steven Anderson, NACDS president and chief executive officer. “This involves maintaining access to necessary medication and preventing the devastation and tragedy of the drug trade and drug abuse.”
NACDS’ work on this issue demonstrates a commitment to three stated priorities of the association—maintaining and advancing the ability of pharmacies to serve patients as an integral part of the health care system, preventing drug abuse and engaging on issues of importance to both the pharmacy and front-end operations of NACDS members.
To become law, the legislation will need to be passed by the House of Representatives and Senate in identical form, and be signed by the President.
PacificHealth stays positive on Accelerade despite disappointment by partner Cadbury
MATAWAN, N.J. PacificHealth Labs on Monday remained positive behind its launch of Accelerade RTD, despite comments from distribution partner Cadbury Schweppes Americas Beverages that the initial launch of the sports beverage was disappointing.
“The number of total Accelerade servings sold in the third quarter is the highest we have ever seen for this product,” stated Robert Portman, PacificHealth president and chief executive offiicer. “This strongly suggests that our audience of users is expanding. … While Cadbury Schweppes has publicly announced their disappointment in sales of Accelerade RTD to date, we are encouraged by our own increase in sales and we will continue to work closely with the CSAB sales and marketing team.”
PacificHealth also announced it will initiate a number of marketing and sales efforts behind its Satiatrim diet aid, including the launch of radio commercials and ads in Women’s World and a major sampling program.
“At the Obesity Society Annual Scientific Meeting in New Orleans this month [Oct. 20 through 24], a study will be presented showing the effectiveness of Satiatrim on slowing gastric emptying,” Portman said. “These results are laying the foundation to allow us to incorporate the Satiatrim technology into new forms and to develop new products that are even more efficacious with a greater duration of action.”